Evidence map›Paper›PMID 25483588›Full record

ArticleChannels (Austin, Tex.)2014

The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels.

María A Gandini, Alejandro Sandoval, Gerald W Zamponi, Ricardo Felix

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Channels (Austin, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The MAP1B Binding Domain of NaThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  5. Article
  6. MAP1B Light Chain Modulates Synaptic Transmission via AMPA Receptor Intracellular Trapping.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

María A Gandinia Department of Cell Biology; Center for Research and Advanced Studies of the National Polytechnic Institute ; Mexico City , Mexico.
Alejandro Sandoval
Gerald W Zamponi
Ricardo Felix
Tecnológico Nacional de México · MXAllen Institute for Brain Science · USAutonomous University of Tlaxcala · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reported recently a new mechanism by which the neuronal N-type Ca(2+) (CaV2.2) channel expression may be regulated by ubiquitination. This mechanism involves the interaction between the channel and the light chain (LC1) of the microtubule associated protein B (MAP1B). We also showed that MAP1B-LC1 could interact with the ubiquitin-conjugating E2 enzyme UBE2L3 and that the ubiquitination/degradation mechanism triggered by MAP1B-LC1 could be prevented by inhibiting the ubiquitin-proteasome proteolytic pathway. We now report that MAP1B-LC1 can interact with the 2 main variants of the CaV2.2 channels (CaV2.2e37a and CaV2.2e37b) and that the MAP1B-LC1-mediated regulation most likely involves an internalization of the channels via a dynamin and clathrin-dependent pathway. In addition, here we propose that this novel mechanism of CaV channel regulation might be conserved among N-type and P/Q-type channels.

Indexed as

BiocatalysisCalcium Channels, N-TypeCells, CulturedHEK293 CellsHumansMicrotubule-Associated ProteinsUbiquitin-Conjugating EnzymesCalcium Channels, N-TypeMAP1B protein, humanMicrotubule-Associated ProteinsUBE2L3 protein, humanUbiquitin-Conjugating EnzymesBFA, brefeldin ABrefeldin ADRG, dorsal root ganglionDynasoreHVA, high-voltage-activatedLC1MAP1BMAP1B-LC1, Microtubule-associated protein 1B light chainN-type channelstraffickingUBE2L3UBE2L3, Ubiquitin-conjugating enzyme E2 L3UPS, Ubiquitin proteasome system

Identifiers

PMID25483588
PMCPMC4594605
OpenAlexW2131939645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.